These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

587 related articles for article (PubMed ID: 15571798)

  • 1. Fluorescence in situ hybridization characterization of different cryptic BCR-ABL rearrangements in chronic myeloid leukemia.
    Haigh S; Cuthbert G
    Cancer Genet Cytogenet; 2004 Dec; 155(2):132-7. PubMed ID: 15571798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BCR/ABL rearrangement in two cases of Philadelphia chromosome negative chronic myeloid leukemia: deletion on the derivative chromosome 9 may or not be present.
    Batista DA; Hawkins A; Murphy KM; Griffin CA
    Cancer Genet Cytogenet; 2005 Dec; 163(2):164-7. PubMed ID: 16337861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Ph-negative chronic myeloid leukemia with a complex BCR/ABL rearrangement and a t(6;9)(p21;q34.1).
    Todorić-Zivanović B; Marisavljević D; Surace C; Cemerikić V; Marković O; Krtolica K; Tatomirović Z; Cikota B; Magić Z; Rocchi M
    Cancer Genet Cytogenet; 2006 Apr; 166(2):180-5. PubMed ID: 16631477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of complex Ph translocations in cases with chronic myelogenous leukemia and one with acute lymphoblastic leukemia.
    Costa D; Carrió A; Madrigal I; Arias A; Valera A; Colomer D; Aguilar JL; Teixido M; Camós M; Cervantes F; Campo E
    Cancer Genet Cytogenet; 2006 Apr; 166(1):89-93. PubMed ID: 16616117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of BCR/ABL gene rearrangements by interphase fluorescence in situ hybridization (FISH) in BCR/ABL+ leukemias: incidence and underlying genetic abnormalities.
    Primo D; Tabernero MD; Rasillo A; Sayagués JM; Espinosa AB; Chillón MC; Garcia-Sanz R; Gutierrez N; Giralt M; Hagemeijer A; San Miguel JF; Orfao A
    Leukemia; 2003 Jun; 17(6):1124-9. PubMed ID: 12764379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Home-brew" FISH assay shows higher efficiency than BCR-ABL dual color, dual fusion probe in detecting microdeletions and complex rearrangements associated with t(9;22) in chronic myeloid leukemia.
    Albano F; Anelli L; Zagaria A; Archidiacono N; Liso V; Specchia G; Rocchi M
    Cancer Genet Cytogenet; 2007 Apr; 174(2):121-6. PubMed ID: 17452253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A fluorescence in situ hybridization study of complex t(9;22) in two chronic myelocytic leukemia cases with a masked Philadelphia chromosome.
    Zagaria A; Anelli L; Albano F; Storlazzi CT; Liso A; Roberti MG; Buquicchio C; Liso V; Rocchi M; Specchia G
    Cancer Genet Cytogenet; 2004 Apr; 150(1):81-5. PubMed ID: 15041230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complex chromosome rearrangements may locate the bcr/abl fusion gene sites other than 22q11.
    Sessarego M; Fugazza G; Bruzzone R; Ballestrero A; Miglino M; Bacigalupo A
    Haematologica; 2000 Jan; 85(1):35-9. PubMed ID: 10629589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic myeloid leukemia with a rare variant BCR-ABL translocation: t(9;22;21)(q34;q11.2;q11.2).
    Takeuchi M; Katayama Y; Okamura A; Yamamoto K; Shimoyama M; Matsui T
    Cancer Genet Cytogenet; 2007 Nov; 179(1):85-7. PubMed ID: 17981222
    [No Abstract]   [Full Text] [Related]  

  • 10. [Fluorescent in-situ hybridization technique (FISH) in the diagnosis of Philadelphia translocation in chronic myeloid leukemia].
    Martinet D; Mühlematter D; Jotterand Bellomo M
    Schweiz Med Wochenschr; 1996 May; 126(20):855-63. PubMed ID: 8685681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Masked Philadelphia chromosome due to atypical BCR/ABL localization on the 9q34 band and duplication of the der(9) in a case of chronic myelogenous leukemia.
    Fugazza G; Garuti A; Marchelli S; Miglino M; Bruzzone R; Gatti AM; Castello S; Sessarego M
    Cancer Genet Cytogenet; 2005 Dec; 163(2):173-5. PubMed ID: 16337863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular cytogenetic characterization of deletions on der(9) in chronic myelocytic leukemia.
    Zagaria A; Anelli L; Albano F; Vicari L; Schiavone EM; Annunziata M; Pane F; Liso V; Rocchi M; Specchia G
    Cancer Genet Cytogenet; 2006 Jun; 167(2):97-102. PubMed ID: 16737907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p190 bcr-abl rearrangement: a secondary cytogenetic event in some chronic myeloid disorders?
    Roumier C; Daudignon A; Soenen V; Dupriez B; Wetterwald M; Lai JL; Cosson A; Fenaux P; Preudhomme C
    Haematologica; 1999 Dec; 84(12):1075-80. PubMed ID: 10586207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of fluorescence in situ hybridization in defining a complex t(9;21;22) Ph formation.
    Mancini M; Nanni M; Cedrone M; De Cuia MR; Rondinelli MB; Malagnino F; Alimena G
    Haematologica; 1994; 79(6):536-9. PubMed ID: 7896212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogenic molecular basis for loss of ABL1-BCR transcription: deletions in der(9)t(9;22) and variants of standard t(9;22) in BCR-ABL1-positive chronic myeloid leukemia.
    Loncarevic IF; Römer J; Starke H; Heller A; Bleck C; Ziegler M; Fiedler W; Liehr T; Clement JH; Claussen U
    Genes Chromosomes Cancer; 2002 Jun; 34(2):193-200. PubMed ID: 11979553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A masked BCR/ABL rearrangement in a case of chronic myeloid leukemia with translocation t(3;9)(p14;q34).
    Bennour A; Sennana H; Laatiri MA; Khelif A; Saad A
    Cancer Genet Cytogenet; 2008 Feb; 181(1):72-4. PubMed ID: 18262060
    [No Abstract]   [Full Text] [Related]  

  • 17. Chronic myelogenous leukemia with the e6a2 BCR-ABL and lacking imatinib response: presentation of two cases.
    Vefring HK; Gruber FX; Wee L; Hovland R; Hjorth-Hansen H; Gedde Dahl T; Meyer P
    Acta Haematol; 2009; 122(1):11-6. PubMed ID: 19641300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular cytogenetics of chronic myeloid leukemia with atypical t(6;9) (p23;q34) translocation.
    Jadayel D; Calabrese G; Min T; van Rhee F; Swansbury GJ; Dyer MJ; Maitland J; Palka G; Catovsky D
    Leukemia; 1995 Jun; 9(6):981-7. PubMed ID: 7596189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ABL gene fuses BCR during t(20;22) results in Philadelphia-negative, but BCR/ABL-positive chronic myeloid leukemia.
    Ito Y; Shimamoto T; Kuriyama Y; Nakajima A; Sumi M; Watanabe Y; Beppu H; Ohtsubo K; Ohyashiki K
    Leukemia; 2002 May; 16(5):951-2. PubMed ID: 11986960
    [No Abstract]   [Full Text] [Related]  

  • 20. A study on the incidence of ABL gene deletion on derivative chromosome 9 in chronic myelogenous leukemia by interphase fluorescence in situ hybridization and its association with disease progression.
    Lee DS; Lee YS; Yun YS; Kim YR; Jeong SS; Lee YK; She CJ; Yoon SS; Shin HR; Kim Y; Cho HI
    Genes Chromosomes Cancer; 2003 Jul; 37(3):291-9. PubMed ID: 12759927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.